What does Zhejiang Orient Gene Biotech Co., Ltd do?

Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) operates in the Medical - Specialties industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 688298.SS's market cap?

Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) has a market capitalization of approximately $3.94 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 688298.SS pay a dividend?

Yes — Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 688298.SS profitable?

Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

688298.SS

Zhejiang Orient Gene Biotech Co., Ltd

SHH·Medical, Specialties · Healthcare

¥19.54¥0.31+1.61%

Market cap¥3.94B·Aug 26 7:00 AM UTC

Price Chart

¥19.54+¥0.31 (+1.61%)today

−82.39%CAGR −29.35%

Select date range

FromTo

Feb 5, 2020Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)¥0.00

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend¥1.67

Ex-Dividend DateJun 26

Payment DateJun 26

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateApr 26

Last Report DateApr 28

Reported vs Estimate−¥0.49

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥1.02B

Net Income−¥542.01M

Net Margin−53.0%

Operating Cash Flow−¥167.87M

Capital Expenditures¥287.79M

Free Cash Flow−¥455.66M

Return on Equity−9.2%

Return on Invested Capital−1.1%

Net Cash¥2.20B

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 688298.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 688298.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 688298.SS and 80,000+ other tickers.

About Zhejiang Orient Gene Biotech Co., Ltd

Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagnosis; and quantum-beads multiplex. Zhejiang Orient Gene Biotech Co., Ltd was founded in 2005 and is based in Huzhou, China.

CEO: Xiao Liang Fang
Sector: Healthcare
Industry: Medical - Specialties
Exchange: SHH
Employees: 2,283
Website: www.orientgene.com

Peers

Peers Tab

002022.SZ

Shanghai Kehua Bio-engineering Co., Ltd.

Nanjing Vishee Medical Technology Co., Ltd

Cap

¥4.5B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 688298.SS

What does Zhejiang Orient Gene Biotech Co., Ltd do?: Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) operates in the Medical - Specialties industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 688298.SS's market cap?: Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) has a market capitalization of approximately $3.94 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 688298.SS pay a dividend?: Yes — Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 688298.SS profitable?: Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.